p38α Selective MAP kinase inhibitor, SD-282, reduces inflammation in a sub-chronic model of tobacco smoke-induced airway inflammation

Satyanarayana Medicherla; Mary Fitzgerald; Dianne Spicer; Paul Woodman; Jing Y. Ma; Ann M. Kapoun; Sarvajit Chakravarty; Sundeep Dugar; Andrew A. Protter; Linda S. Higgins

doi:10.1124/jpet.107.127092

OtherInflammation, Immunopharmacology, and Asthma

p38α Selective MAP kinase inhibitor, SD-282, reduces inflammation in a sub-chronic model of tobacco smoke-induced airway inflammation

Satyanarayana Medicherla, Mary Fitzgerald, Dianne Spicer, Paul Woodman, Jing Y. Ma, Ann M. Kapoun, Sarvajit Chakravarty, Sundeep Dugar, Andrew A. Protter and Linda S. Higgins

Journal of Pharmacology and Experimental Therapeutics December 4, 2007, DOI: https://doi.org/10.1124/jpet.107.127092

Satyanarayana Medicherla

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mary Fitzgerald

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Dianne Spicer

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Paul Woodman

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jing Y. Ma

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ann M. Kapoun

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sarvajit Chakravarty

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sundeep Dugar

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Andrew A. Protter

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Linda S. Higgins

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
eLetters
PDF

This is a PDF-only article. The first page of the PDF of this article appears above.

In this issue

Journal of Pharmacology and Experimental Therapeutics

Vol. 390, Issue 3

1 Sep 2024

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Editorial Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following p38α Selective MAP kinase inhibitor, SD-282, reduces inflammation in a sub-chronic model of tobacco smoke-induced airway inflammation

Message Subject (Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics

Message Body (Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

OtherInflammation, Immunopharmacology, and Asthma

p38α Selective MAP kinase inhibitor, SD-282, reduces inflammation in a sub-chronic model of tobacco smoke-induced airway inflammation

Satyanarayana Medicherla, Mary Fitzgerald, Dianne Spicer, Paul Woodman, Jing Y. Ma, Ann M. Kapoun, Sarvajit Chakravarty, Sundeep Dugar, Andrew A. Protter and Linda S. Higgins

Journal of Pharmacology and Experimental Therapeutics December 4, 2007, DOI: https://doi.org/10.1124/jpet.107.127092

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

OtherInflammation, Immunopharmacology, and Asthma

p38α Selective MAP kinase inhibitor, SD-282, reduces inflammation in a sub-chronic model of tobacco smoke-induced airway inflammation

Satyanarayana Medicherla, Mary Fitzgerald, Dianne Spicer, Paul Woodman, Jing Y. Ma, Ann M. Kapoun, Sarvajit Chakravarty, Sundeep Dugar, Andrew A. Protter and Linda S. Higgins

Journal of Pharmacology and Experimental Therapeutics December 4, 2007, DOI: https://doi.org/10.1124/jpet.107.127092

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Info & Metrics
eLetters
PDF

Main menu

User menu

Search

p38α Selective MAP kinase inhibitor, SD-282, reduces inflammation in a sub-chronic model of tobacco smoke-induced airway inflammation

In this issue

p38α Selective MAP kinase inhibitor, SD-282, reduces inflammation in a sub-chronic model of tobacco smoke-induced airway inflammation

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Navigate

More Information

ASPET's Other Journals